JPWO2022153907A1 - - Google Patents
Info
- Publication number
- JPWO2022153907A1 JPWO2022153907A1 JP2022575548A JP2022575548A JPWO2022153907A1 JP WO2022153907 A1 JPWO2022153907 A1 JP WO2022153907A1 JP 2022575548 A JP2022575548 A JP 2022575548A JP 2022575548 A JP2022575548 A JP 2022575548A JP WO2022153907 A1 JPWO2022153907 A1 JP WO2022153907A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021004184 | 2021-01-14 | ||
PCT/JP2022/000138 WO2022153907A1 (ja) | 2021-01-14 | 2022-01-05 | ネフローゼ症候群の診断を補助するためのマーカー及びその使用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2022153907A1 true JPWO2022153907A1 (ja) | 2022-07-21 |
JPWO2022153907A5 JPWO2022153907A5 (ja) | 2023-12-05 |
Family
ID=82447286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022575548A Pending JPWO2022153907A1 (ja) | 2021-01-14 | 2022-01-05 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20240003915A1 (ja) |
EP (1) | EP4261540A1 (ja) |
JP (1) | JPWO2022153907A1 (ja) |
KR (1) | KR20230126221A (ja) |
CN (1) | CN116745620A (ja) |
WO (1) | WO2022153907A1 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
US8372954B2 (en) | 2000-12-22 | 2013-02-12 | National Research Council Of Canada | Phage display libraries of human VH fragments |
WO2010019565A2 (en) * | 2008-08-12 | 2010-02-18 | Medlmmune, Llc | Anti-ephrin b2 antibodies and their use in treatment of disease |
JP6770741B2 (ja) * | 2016-10-07 | 2020-10-21 | 国立大学法人 新潟大学 | ネフローゼ症候群の予防薬又は治療薬をスクリーニングする方法、ネフローゼ症候群の予防又は治療用医薬組成物、ネフローゼ症候群診断用マーカー、ネフローゼ症候群の検査方法、及びネフローゼ症候群の診断用試薬 |
JP2021004184A (ja) | 2019-06-25 | 2021-01-14 | 小林製薬株式会社 | アラントイン及び/又はその誘導体の安定化方法 |
-
2022
- 2022-01-05 EP EP22738330.4A patent/EP4261540A1/en active Pending
- 2022-01-05 US US18/271,660 patent/US20240003915A1/en active Pending
- 2022-01-05 JP JP2022575548A patent/JPWO2022153907A1/ja active Pending
- 2022-01-05 CN CN202280009841.1A patent/CN116745620A/zh active Pending
- 2022-01-05 WO PCT/JP2022/000138 patent/WO2022153907A1/ja active Application Filing
- 2022-01-05 KR KR1020237026023A patent/KR20230126221A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
KR20230126221A (ko) | 2023-08-29 |
US20240003915A1 (en) | 2024-01-04 |
CN116745620A (zh) | 2023-09-12 |
EP4261540A1 (en) | 2023-10-18 |
WO2022153907A1 (ja) | 2022-07-21 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20230623 |